Skip to contentA
Abbott Laboratories
A
ABTAbbott Laboratories Q3 2011 · 10-Q
Revenue$9.82B$9.82B+13.2% vs Q3 2010 Net Income$303.20M$303.20M−66.0% vs Q3 2010 EPS Diluted$0.19$0.19−66.7% vs Q3 2010 Gross Profit$5,843,400,000+18.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Abbott Laboratories · CIK 1800 · Engraved from SEC EDGAR
Operating Cash Flowderived$3,054,430,000+19.9% Free Cash Flowderived$2,602,435,000+11.1% Margins · derivedGross margin59.5%+2.7 pt vs Q3 2010
Operating margin6.1%−7.6 pt vs Q3 2010
Net margin3.1%−7.2 pt vs Q3 2010
ended Sep 30, 2011 · filed Nov 4, 2011 · 35 d after period end